TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
64 insider filings · Latest: Jun 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Feb 28 4:52 PM | Kalif Eliyahu Sharon | Proposed Sale | 55,750 | $16.21 | $903.5K | — | View → |
| Feb 18, 2025 | Feb 18 5:38 PM | Francis Richard D | Proposed Sale | 75,506 | $16.95 | $1.3M | — | View → |
| Feb 12, 2025 | Feb 13 1:06 PM | Sabag Mark | Proposed Sale | 177,626 | $16.25 | $2.9M | — | View → |
| Dec 20, 2024 | Dec 21 12:03 AM | Bridger Management, LLC (1) | Proposed Sale | 286,000 | $21.31 | $6.1M | — | View → |
| Nov 20, 2024 | Nov 20 4:39 PM | Fox Christine | Proposed Sale | 19,388 | $16.87 | $327.1K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Jan 29 9:04 PM | Mark SabagSee "Remarks" | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:02 PM | Richard DaniellExec. VP, European Commercial | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:01 PM | Richard D FrancisPresident and CEO | Grant/Award | 1,511,425 | — | 891,315(D) | View → |
← Previous
Page 4 of 4